Fortress Biotech, Inc. (FBIO) Return on equity 2016–2025
Fortress Biotech, Inc. (FBIO) return on equity by fiscal year — reported net income divided by year-end shareholders’ equity.
74.2%FY2025 · since FY2016: -143.1% → 74.2%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | 74.2% | -18.2 pp |
| FY2024 | 92.4% | -45.1 pp |
| FY2023 | 137.5% | +345.0 pp |
| FY2022 | -207.5% | -148.0 pp |
| FY2021 | -59.5% | -13.2 pp |
| FY2020 | -46.4% | +106.1 pp |
| FY2019 | -152.4% | +4391.1 pp |
| FY2018 | -4543.6% | -4416.4 pp |
| FY2017 | -127.2% | +15.9 pp |
| FY2016 | -143.1% | — |
ROE = reported net income ÷ reported year-end shareholders’ equity for the same fiscal year. Heavy buybacks shrink equity and can push ROE very high (or negative-equity years drop out).
Source: SEC XBRL filings · For reference only · Not investment advice